Deepak Nitrite (DEEPAKNTR) Q3 2025 earnings summary

Executive summary

• Q3 and nine-month FY25 results were impacted by lagged agrochemical demand, high raw material costs, project commissioning delays, and oversupply from China, leading to margin contraction.

• Q3 FY25 total income was ₹1,924 crore, down 5% YoY and 6% QoQ; 9M FY25 total income reached ₹6,163 crore, up 10% YoY.

• Q3 FY25 consolidated net profit was ₹98 crore, down 51% YoY; 9M FY25 PAT was ₹495 crore, down 11% YoY.

• Management remains confident in recovery and sustained growth from Q4 onwards, supported by new product introductions and capacity expansions.

• Board approved unaudited results for Q3 and 9M FY25; limited review reports confirmed no material misstatements.

Financial highlights

• Q3 FY25 consolidated revenue was ₹1,924 crore, down 5% YoY and 6% QoQ; 9M FY25 revenue grew 10% YoY to ₹6,163 crore.

• Q3 FY25 EBITDA was ₹190 crore, down 40% YoY; 9M FY25 EBITDA at ₹836 crore, down 5% YoY.

• Q3 FY25 PAT was ₹98 crore; 9M FY25 PAT was ₹495 crore.

• Q3 FY25 EBITDA margin dropped to 10% from 16% YoY; 9M FY25 EBITDA margin at 14% (down from 16%).

• EPS for Q3 FY25 was ₹7.19; 9M FY25 EPS was ₹36.28.

Outlook and guidance

• Margin recovery expected as demand stabilizes, new projects ramp up, and cost optimization takes effect.

• Q4 and Q1 are projected to show meaningful improvement, with normalization anticipated between Q1 and Q2.

• Strategic investments in new product development and market expansion to drive long-term growth.

• Major projects (nitric acid, MIBK/MIBC, acetophenone) to be commissioned in FY25–H1 FY26; polymer business expansion underway.